Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S ( (DE:2TZ) ) has shared an announcement.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited reported that there have been no material developments in the bankruptcy liquidation of its 55%-owned subsidiary, Tianjin Shin Poong Pharmaceutical Co., Ltd., since the previous monthly update. The board stated that the proceedings currently have no significant impact on the group’s financial position, and the company will continue to monitor the case, liaise with the court and administrator, and issue monthly updates while advising shareholders and investors to remain cautious when trading its shares.
More about Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited, is a China-based pharmaceutical group. The company operates through various subsidiaries to produce and distribute pharmaceutical products in the domestic market and potentially overseas.
Find detailed analytics on 2TZ stock on TipRanks’ Stock Analysis page.